These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study. Bruno F; Baratti D; Martinetti A; Morelli D; Sottotetti E; Bonini C; Guaglio M; Kusamura S; Deraco M Eur J Surg Oncol; 2018 Jun; 44(6):792-798. PubMed ID: 29503128 [TBL] [Abstract][Full Text] [Related]
10. Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma. Creaney J; Segal A; Olsen N; Dick IM; Musk AW; Skates SJ; Robinson BW Dis Markers; 2014; 2014():413946. PubMed ID: 25505814 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology. Canessa PA; Franceschini MC; Ferro P; Battolla E; Dessanti P; Manta C; Sivori M; Pezzi R; Fontana V; Fedeli F; Pistillo MP; Roncella S Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166 [TBL] [Abstract][Full Text] [Related]
12. Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. Cristaudo A; Bonotti A; Simonini S; Vivaldi A; Guglielmi G; Ambrosino N; Chella A; Lucchi M; Mussi A; Foddis R J Thorac Oncol; 2011 Sep; 6(9):1587-93. PubMed ID: 21642872 [TBL] [Abstract][Full Text] [Related]
13. Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer? Lee YC Thorax; 2007 Jul; 62(7):561-2. PubMed ID: 17600291 [No Abstract] [Full Text] [Related]
17. Prognostication and monitoring of mesothelioma using biomarkers: a systematic review. Arnold DT; De Fonseka D; Hamilton FW; Rahman NM; Maskell NA Br J Cancer; 2017 Mar; 116(6):731-741. PubMed ID: 28170372 [TBL] [Abstract][Full Text] [Related]
18. Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels. Rai AJ; Flores RM; Mathew A; Gonzalez-Espinoza R; Bott M; Ladanyi M; Rusch V; Fleisher M Clin Chem Lab Med; 2010 Feb; 48(2):271-8. PubMed ID: 20131968 [TBL] [Abstract][Full Text] [Related]
19. The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies. Galloway ML; Murray D; Moffat DF Histopathology; 2006 May; 48(6):767-9. PubMed ID: 16681698 [No Abstract] [Full Text] [Related]
20. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Creaney J; van Bruggen I; Hof M; Segal A; Musk AW; de Klerk N; Horick N; Skates SJ; Robinson BW Chest; 2007 Oct; 132(4):1239-46. PubMed ID: 17646232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]